Nitric oxide and murine coxsackievirus B3 myocarditis: Aggravation of myocarditis by inhibition of nitric oxide synthase

Journal of the American College of Cardiology

Volumn 28, Issue 6, 1996, Pages 1610-1615

  Hiraoka, Yuji ^a   Kishimoto, Chiharu ^a   Takada, Hitoshi ^a   Nakamura, Michiyo ^a   Kurokawa, Masahiko ^a   Ochiai, Hiroshi ^a   Shiraki, Kimiyasu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; ENANTIOMER; ENZYME INHIBITION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VIRUS MYOCARDITIS; VIRUS REPLICATION;

ANIMALS; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; ENZYME INHIBITORS; MACROPHAGES; MICE; MYOCARDITIS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; VIREMIA; VIRUS REPLICATION;

EID: 0030588989     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00372-5     Document Type: Article

References (28)

1. 1. Abelmann WH. Viral myocarditis and its sequelae. Annu Rev Med 1973; 24:145-542.
2. 2. Woodruff JF. Viral myocarditis: a review. Am J Pathol 1980;101:427-84.
3. 3. Reyes M, Lerner AM. Coxsackievirus myocarditis: with special reference to acute and chronic effects. Prog Cardiovasc Dis 1985;27:373-94.
4. 4. Kishimoto C, Misaki T, Crumpacker CS, Abelmann WH. Serial immunological identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in heart and in peripheral blood. Circulation 1988;77:645-53.
5. 5. Kishimoto C, Abelmann WH. In vivo significance of T cells in the development of coxsackievirus B3 myocarditis in mice: immature but antigen-specific T cells aggravate cardiac injury. Circ Res 1990;67:589-98.
6. 6. Kishimoto C, Kawai C, Abelmann WH. Immuno-genetic aspects of the pathogenesis of experimental viral myocarditis. In: Kawai C, Abelmann WH, editors. Cardiomyopathy 1987. Pathogenesis of Myocarditis and Cardiomyopathy: Experimental and Clinical Studies. Tokyo: University of Tokyo Press, 1987:3-7.
7. 7. Hiraoka Y, Kishimoto C, Kurokawa M, Ochiai H, Sasayama S. Effects of polyethylene glycol conjugated Superoxide dismutase on coxsackievirus B3 myocarditis in mice. Cardiovasc Res 1992;26:956-61.
8. 8. Kishimoto C, Kuroki Y, Hiraoka Y, Ochiai H, Kurokawa M, Sasayama S. Cytokine and murine coxsackievirus B3 myocarditis: interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage. Circulation 1994;28:2836-42.
9. 9. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
10. 10. Bredt DS, Synder SH. Nitric oxide, a novel neural messenger. Neuron 1992;8:3-11.
11. 11. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 1991;14:60-7.
12. 12. Nathan CF, Hibbs JB. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991;3:65-70.
13. 13. Moncada S. The L-arginine: nitric oxide pathway. Acta Physiol Scand 1992;145:201-27.
14. 14. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
15. 15. Croen KD. Evidence for an antiviral effect of nitric oxide: inhibition of herpes simplex virus type 1 replication. J Clin Invest 1993;91:2446-52.
16. 16. Karupiah G, Wie QW, Buller RML, Nathan C, Duarte C, MacMiking JD. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 1993;261:1445-8.
17. 17. Raschke WC, Baird S, Ralph P, Nakoinz I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 1978;15:261-7.
18. 18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-62.
19. 19. Lowenstein C, Allen G, Walker A, Rose N, Snyder S, Herskowitz A. Nitric oxide inhibits viral replication in myocarditis [abstract]. Circulation 1993;88 Suppl 1:I-G-H.
20. 20. Mulligan MS, Hevel JM, Marietta MA, Ward PA. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad SCi USA 1991;88:6338-42.
21. 21. Miller MJS, Sadowska-Krowicka H, Chotinaruemol S, Kakkis JL, Clark DA. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 1993;264:11-6.
22. 22. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of cholesterolemic patients. Circulation 1993;88:2541-7.
23. 23. Wang B-Y, Singer AH, Tsao PS, Drexler H, Kosek J, Cooke JP. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. J Am Coll Cardiol 1994;23:452-8.
24. 24. Tsao P, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994;89:2176-82.
25. 25. Kurose I, Wolf R, Grisham MB, Granger DN. Modulation of ischemia/ reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 1994;74:376-82.
26. 26. Hasebe N, Shen Y-T, Vatner SF. Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dogs. Circulation 1993 ;88: 2862-71.
27. 27. Garg U, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-7.
28. 28. Khaidar A, Marx M, Lubec B, Lubec G. L-Arginine reduces heart collagen accumulation in the diabetic db/db mouse. Circulation 1994;90:479-83.